Further mechanistic studies revealed that prevention of atherosclerosis by FGF21 was attributed to the fine-tuning of multiorgan cross talk among the liver, adipose tissue, and blood vessels, characterized by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice with atherosclerosis [35]. The gene discussed is FGF21; the disease is atherosclerosis.